Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Viral Detection Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Plaque Assays
  • 1.4.3 PCR
  • 1.4.4 ELISA
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Viral Detection Market Share by Application (2014-2025)
  • 1.5.2 Blood & Blood Products
  • 1.5.3 Cellular & Gene Therapy Products
  • 1.5.4 Stem Cell Products
  • 1.5.5 Tissue & Tissue Products
  • 1.5.6 Vaccines and Therapeutics
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Viral Detection Market Size
• 2.2 Viral Detection Growth Trends by Regions
  • 2.2.1 Viral Detection Market Size by Regions (2014-2025)
  • 2.2.2 Viral Detection Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Viral Detection Market Size by Manufacturers
  • 3.1.1 Global Viral Detection Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Viral Detection Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Viral Detection Market Concentration Ratio (CR5 and HHI)
• 3.2 Viral Detection Key Players Head office and Area Served
• 3.3 Key Players Viral Detection Product/Solution/Service
• 3.4 Date of Enter into Viral Detection Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Viral Detection Market Size by Type (2014-2019)
• 4.2 Global Viral Detection Market Size by Application (2014-2019)

5 United States

• 5.1 United States Viral Detection Market Size (2014-2019)
• 5.2 Viral Detection Key Players in United States
• 5.3 United States Viral Detection Market Size by Type
• 5.4 United States Viral Detection Market Size by Application

6 Europe

• 6.1 Europe Viral Detection Market Size (2014-2019)
• 6.2 Viral Detection Key Players in Europe
• 6.3 Europe Viral Detection Market Size by Type
• 6.4 Europe Viral Detection Market Size by Application

7 China

• 7.1 China Viral Detection Market Size (2014-2019)
• 7.2 Viral Detection Key Players in China
• 7.3 China Viral Detection Market Size by Type
• 7.4 China Viral Detection Market Size by Application

8 Japan

• 8.1 Japan Viral Detection Market Size (2014-2019)
• 8.2 Viral Detection Key Players in Japan
• 8.3 Japan Viral Detection Market Size by Type
• 8.4 Japan Viral Detection Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Viral Detection Market Size (2014-2019)
• 9.2 Viral Detection Key Players in Southeast Asia
• 9.3 Southeast Asia Viral Detection Market Size by Type
• 9.4 Southeast Asia Viral Detection Market Size by Application

10 India

• 10.1 India Viral Detection Market Size (2014-2019)
• 10.2 Viral Detection Key Players in India
• 10.3 India Viral Detection Market Size by Type
• 10.4 India Viral Detection Market Size by Application

11 Central & South America

• 11.1 Central & South America Viral Detection Market Size (2014-2019)
• 11.2 Viral Detection Key Players in Central & South America
• 11.3 Central & South America Viral Detection Market Size by Type
• 11.4 Central & South America Viral Detection Market Size by Application

12 International Players Profiles

• 12.1 Avance Biosciences Inc. (U.S.)
  • 12.1.1 Avance Biosciences Inc. (U.S.) Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Viral Detection Introduction
  • 12.1.4 Avance Biosciences Inc. (U.S.) Revenue in Viral Detection Business (2014-2019)
  • 12.1.5 Avance Biosciences Inc. (U.S.) Recent Development
• 12.2 BSL BIOSERVICE (Germany)
  • 12.2.1 BSL BIOSERVICE (Germany) Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Viral Detection Introduction
  • 12.2.4 BSL BIOSERVICE (Germany) Revenue in Viral Detection Business (2014-2019)
  • 12.2.5 BSL BIOSERVICE (Germany) Recent Development
• 12.3 Clean Cells (France)
  • 12.3.1 Clean Cells (France) Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Viral Detection Introduction
  • 12.3.4 Clean Cells (France) Revenue in Viral Detection Business (2014-2019)
  • 12.3.5 Clean Cells (France) Recent Development
• 12.4 Charles River Laboratories International, Inc. (U.S.)
  • 12.4.1 Charles River Laboratories International, Inc. (U.S.) Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Viral Detection Introduction
  • 12.4.4 Charles River Laboratories International, Inc. (U.S.) Revenue in Viral Detection Business (2014-2019)
  • 12.4.5 Charles River Laboratories International, Inc. (U.S.) Recent Development
• 12.5 Lonza Group (Switzerland)
  • 12.5.1 Lonza Group (Switzerland) Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Viral Detection Introduction
  • 12.5.4 Lonza Group (Switzerland) Revenue in Viral Detection Business (2014-2019)
  • 12.5.5 Lonza Group (Switzerland) Recent Development
• 12.6 Merck KGaA (Germany)
  • 12.6.1 Merck KGaA (Germany) Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Viral Detection Introduction
  • 12.6.4 Merck KGaA (Germany) Revenue in Viral Detection Business (2014-2019)
  • 12.6.5 Merck KGaA (Germany) Recent Development
• 12.7 Sigma-Aldrich Corporation (U.S.)
  • 12.7.1 Sigma-Aldrich Corporation (U.S.) Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Viral Detection Introduction
  • 12.7.4 Sigma-Aldrich Corporation (U.S.) Revenue in Viral Detection Business (2014-2019)
  • 12.7.5 Sigma-Aldrich Corporation (U.S.) Recent Development
• 12.8 SGS S.A. (Switzerland)
  • 12.8.1 SGS S.A. (Switzerland) Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Viral Detection Introduction
  • 12.8.4 SGS S.A. (Switzerland) Revenue in Viral Detection Business (2014-2019)
  • 12.8.5 SGS S.A. (Switzerland) Recent Development
• 12.9 Texcell, Inc. (France)
  • 12.9.1 Texcell, Inc. (France) Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Viral Detection Introduction
  • 12.9.4 Texcell, Inc. (France) Revenue in Viral Detection Business (2014-2019)
  • 12.9.5 Texcell, Inc. (France) Recent Development
• 12.10 WuXi PharmaTech (Cayman) Inc. (China)
  • 12.10.1 WuXi PharmaTech (Cayman) Inc. (China) Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Viral Detection Introduction
  • 12.10.4 WuXi PharmaTech (Cayman) Inc. (China) Revenue in Viral Detection Business (2014-2019)
  • 12.10.5 WuXi PharmaTech (Cayman) Inc. (China) Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

In 2018, the global Viral Detection market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global Viral Detection status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Viral Detection development in United States, Europe and China.

The key players covered in this study
Avance Biosciences Inc. (U.S.)
BSL BIOSERVICE (Germany)
Clean Cells (France)
Charles River Laboratories International, Inc. (U.S.)
Lonza Group (Switzerland)
Merck KGaA (Germany)
Sigma-Aldrich Corporation (U.S.)
SGS S.A. (Switzerland)
Texcell, Inc. (France)
WuXi PharmaTech (Cayman) Inc. (China)

Market segment by Type, the product can be split into
Plaque Assays
PCR
ELISA
Others

Market segment by Application, split into
Blood & Blood Products
Cellular & Gene Therapy Products
Stem Cell Products
Tissue & Tissue Products
Vaccines and Therapeutics

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Viral Detection status, future forecast, growth opportunity, key market and key players.
To present the Viral Detection development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Viral Detection are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.